Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Benzodiazepine Reference Comparisons: Diazepam, Zolpidem, and Alpha-2/3 Selective Agents

Comparative sleep EEG pharmacology with reference compounds is essential for positioning Selank’s sleep-modulatory profile. Key reference comparisons include: Diazepam (non-selective GABA-A positive allosteric modulator, α1/α2/α3/α5) at anxiolytic doses (1mg/k

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Comparative sleep EEG pharmacology with reference compounds is essential for positioning Selank’s sleep-modulatory profile. Key reference comparisons include:
  • Diazepam (non-selective GABA-A positive allosteric modulator, α1/α2/α3/α5) at anxiolytic doses (1mg/kg i.p.) produces classic benzodiazepine EEG effects: increased NREM sleep time, reduced delta power density (NREM homeostatic sleep pressure paradoxically suppressed despite increased NREM time — the benzodiazepine sleep quality paradox), reduced REM sleep, increased beta spindle frequency (12–16 Hz), and reduced wake.
  • Zolpidem (α1-preferring GABA-A PAM; imidazopyridine Z-drug) at 10mg/kg i.p. increases NREM time with less delta power suppression than diazepam and less REM suppression, better recapitulating physiological sleep architecture. Comparing Selank’s EEG spectral power fingerprint to diazepam and zolpidem allows inferences about its GABA-A subunit selectivity and the quality of sleep architecture changes (quantitative delta power during NREM being the key quality marker).
  • L-838,417 (α2/α3/α5-selective GABA-A PAM; anxiolytic-selective) provides the positive control for an anxiolytic-without-sedation GABA-A modulator profile. If Selank’s sleep EEG profile resembles L-838,417 more than diazepam, this would support α2/α3-preferring GABA-A modulation and anxiolytic-dominant rather than sedative-dominant pharmacology. The presence or absence of delta power suppression during NREM is the critical discriminator.